Aurobindo Pharma witnessed a nearly 9% surge in consolidated net profit for Q2FY25, reaching Rs 817 crore. This growth was fueled by an 8% rise in consolidated revenue, driven by a strong ...

Aurobindo Pharma consolidated net profit for the September quarter increased 8.6% to ₹816.9 crore compared to ₹751.9 crore year earlier. On a sequential basis the net profit was 11% lower ...

As Aurobindo Pharma Foundation (APF), the 108 emergency service provider, has demanded ₹141 crore from the State government for maintenance of ambulances, Telugu Desam Party (TDP) leader and ...

Hyderabad-based Aurobindo Pharma has registered a growth of 8.6 per cent in net profit for the quarter ended September 30, 2024 at Rs. 816.95 crore as compared to Rs. 751.94 crore during the same ...

Aurobindo Pharma (NS:ARBN) has outperformed expectations in the fourth quarter of FY24, with both sales and EBITDA showing significant year-over-year growth. Sales increased by 17%, while EBITDA ...

Aurobindo Pharma's subsidiary, CuraTeQ Biologics, has received a GMP certificate from the European Medicines Agency for its ...

Aurobindo Pharma witnessed an 8.6% YoY increase in net profit, reaching Rs 817 crore in Q2 FY25, driven by robust sales in Europe and growth markets. Despite a dip in US formulations revenue, the ...

Key events include Q2 earnings reports from companies like Asian Paints and Divis Laboratories, and PM Modi's campaign ...

Hyderabad: After declaring the Telangana govt's intention to scrap Hyderabad's Green Pharma City project earlier this year during BioAsia 2024, industries and IT minister Duddilla Sridhar Babu on ...

Aurobindo Pharma Limited (APL), one of the worlds top 5 manufacturers of semi synthetic penicillins was incorporated in 26th December 1986 as a private limited company. Mr. P.V.Ramaprasad Reddy ...

AUROBINDO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2024 inter alia to consider and approve Intimation of Board meeting to be held on ...